Literature DB >> 7818479

Mobilization of intracellular Ca2+ by adenine nucleotides in human T-leukaemia cells: evidence for ADP-specific and P2y-purinergic receptors.

M Biffen1, D R Alexander.   

Abstract

The expression of purinergic receptors on human T-cells was investigated and the receptors were shown to be functionally coupled to intracellular signals in two out of eight T-leukaemia cell-lines. Addition of adenine nucleotides resulted in mobilization of intracellular Ca2+ in HPB-ALL cells and a cell line (CB1) recently isolated from a patient with T-acute lymphoblastic leukaemia. Of a range of nucleotides tested only ADP and ATP elevated intracellular levels of Ca2+, with ADP being the more potent agonist. Ca2+ mobilization by ATP was accompanied by increased inositol phosphate production and was blocked by the purinergic receptor antagonist, Reactive Blue 2, indicating that ATP was interacting with a P2y receptor. Intracellular Ca2+ release triggered by ADP was independent of both inositol phosphate production and protein tyrosine phosphorylation. Expression of the transmembrane phosphotyrosine phosphatase, CD45, had no effect on ADP-stimulated Ca2+ mobilization. Our results show that functional P2y receptors can be expressed on T-cells, and also identify a novel T-cell ADP receptor. Signals mediated by these purinergic receptors could play important roles in modulating T-cell function.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7818479      PMCID: PMC1137400          DOI: 10.1042/bj3040769

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  Tyrosine phosphatase CD45 is required for T-cell antigen receptor and CD2-mediated activation of a protein tyrosine kinase and interleukin 2 production.

Authors:  G A Koretzky; J Picus; T Schultz; A Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

2.  The effects of ATP on platelets: evidence against the central role of released ADP in primary aggregation.

Authors:  D E Macfarlane; D C Mills
Journal:  Blood       Date:  1975-09       Impact factor: 22.113

3.  Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis.

Authors:  C D Gregory; C Dive; S Henderson; C A Smith; G T Williams; J Gordon; A B Rickinson
Journal:  Nature       Date:  1991-02-14       Impact factor: 49.962

4.  A novel pathway for the activation of phospholipase D by P2z purinergic receptors in BAC1.2F5 macrophages.

Authors:  C el-Moatassim; G R Dubyak
Journal:  J Biol Chem       Date:  1992-11-25       Impact factor: 5.157

5.  Inhibition of CD3-linked phospholipase C by phorbol ester and by cAMP is associated with decreased phosphotyrosine and increased phosphoserine contents of PLC-gamma 1.

Authors:  D J Park; H K Min; S G Rhee
Journal:  J Biol Chem       Date:  1992-01-25       Impact factor: 5.157

6.  Adenosine-5'-triphosphate-(ATP) mediated stimulation and suppression of DNA synthesis in lymphoid cells. I. Characterization of ATP responsive cells in mouse lymphoid organs.

Authors:  S Ikehara; R N Pahwa; D G Lunzer; R A Good; M J Modak
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

7.  Expression of GTP-binding proteins and prostaglandin E2 receptors during human T cell activation.

Authors:  W Holter; A M Spiegel; B H Howard; S Weber; M R Brann
Journal:  Cell Immunol       Date:  1991-05       Impact factor: 4.868

8.  Antagonism by reactive blue 2 but not by brilliant blue G of extracellular ATP-evoked responses in PC12 phaeochromocytoma cells.

Authors:  K Inoue; K Nakazawa; M Ohara-Imaizumi; T Obama; K Fujimori; A Takanaka
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

9.  Activation of phospholipase D: a signaling system set in motion by perturbation of the T lymphocyte antigen receptor/CD3 complex.

Authors:  S J Stewart; G R Cunningham; J A Strupp; F S House; L L Kelley; G S Henderson; J H Exton; S B Bocckino
Journal:  Cell Regul       Date:  1991-10

10.  CD45 tyrosine phosphatase-activated p59fyn couples the T cell antigen receptor to pathways of diacylglycerol production, protein kinase C activation and calcium influx.

Authors:  M Shiroo; L Goff; M Biffen; E Shivnan; D Alexander
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

View more
  5 in total

Review 1.  Expression and function of P2 receptors in hematopoietic stem and progenitor cells.

Authors:  Wenli Feng; Lina Wang; Guoguang Zheng
Journal:  Stem Cell Investig       Date:  2015-07-30

Review 2.  P2 receptor subtypes in the cardiovascular system.

Authors:  S P Kunapuli; J L Daniel
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

Review 3.  Purinergic signalling and cancer.

Authors:  Geoffrey Burnstock; Francesco Di Virgilio
Journal:  Purinergic Signal       Date:  2013-12       Impact factor: 3.765

Review 4.  Involvement of P2 receptors in hematopoiesis and hematopoietic disorders, and as pharmacological targets.

Authors:  Kelly Juliana Filippin; Kamylla F S de Souza; Roberto Theodoro de Araujo Júnior; Heron Fernandes Vieira Torquato; Dhébora Albuquerque Dias; Eduardo Benedetti Parisotto; Alice Teixeira Ferreira; Edgar J Paredes-Gamero
Journal:  Purinergic Signal       Date:  2019-12-20       Impact factor: 3.765

5.  Chemotactic activity of extracellular nucleotideson human immune cells.

Authors:  Daniel Myrtek; Marco Idzko
Journal:  Purinergic Signal       Date:  2007-03-08       Impact factor: 3.765

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.